Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An epidemiological forecast model and software assessing interventions on COVID-19 epidemic in China

Lili Wang, Yiwang Zhou, Jie He, Bin Zhu, Fei Wang, Lu Tang, Marisa Eisenberg, View ORCID ProfilePeter X.K. Song
doi: https://doi.org/10.1101/2020.02.29.20029421
Lili Wang
1Department of Biostatistics, University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiwang Zhou
1Department of Biostatistics, University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie He
1Department of Biostatistics, University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bin Zhu
2Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fei Wang
3Data Science Team, CarGurus, Cambridge, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lu Tang
4Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marisa Eisenberg
5Department of Epidemiology, University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter X.K. Song
1Department of Biostatistics, University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter X.K. Song
  • For correspondence: pxsong@umich.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We develop a health informatics toolbox that enables public health workers to timely analyze and evaluate the time-course dynamics of the novel coronavirus (COVID-19) infection using the public available data from the China CDC. This toolbox is built upon a hierarchical epidemiological model in which two observed time series of daily proportions of infected and removed cases are emitted from the underlying infection dynamics governed by a Markov SIR infectious disease process. We extend the SIR model to incorporate various types of time-varying quarantine protocols, including government-level macro isolation policies and community-level micro inspection measures. We develop a calibration procedure for under-reported infected cases. This toolbox provides forecast, in both online and offline forms, of turning points of interest, including the time when daily infected proportion becomes smaller than the previous ones and the time when daily infected proportions becomes smaller than that of daily removed proportion, as well as the ending time of the epidemic. An R software is made available for the public, and examples on the use of this software are illustrated. Some possible extensions of our novel epidemiological models are discussed.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

None.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

We used the publicly available data from the China CDC, which can be accessed at DXY.cn.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 03, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An epidemiological forecast model and software assessing interventions on COVID-19 epidemic in China
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An epidemiological forecast model and software assessing interventions on COVID-19 epidemic in China
Lili Wang, Yiwang Zhou, Jie He, Bin Zhu, Fei Wang, Lu Tang, Marisa Eisenberg, Peter X.K. Song
medRxiv 2020.02.29.20029421; doi: https://doi.org/10.1101/2020.02.29.20029421
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
An epidemiological forecast model and software assessing interventions on COVID-19 epidemic in China
Lili Wang, Yiwang Zhou, Jie He, Bin Zhu, Fei Wang, Lu Tang, Marisa Eisenberg, Peter X.K. Song
medRxiv 2020.02.29.20029421; doi: https://doi.org/10.1101/2020.02.29.20029421

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (577)
  • Anesthesia (139)
  • Cardiovascular Medicine (1942)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (331)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (697)
  • Epidemiology (11090)
  • Forensic Medicine (8)
  • Gastroenterology (620)
  • Genetic and Genomic Medicine (3159)
  • Geriatric Medicine (307)
  • Health Economics (561)
  • Health Informatics (2040)
  • Health Policy (862)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12702)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2979)
  • Nursing (163)
  • Nutrition (462)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1548)
  • Ophthalmology (476)
  • Orthopedics (185)
  • Otolaryngology (265)
  • Pain Medicine (201)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (910)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (354)
  • Psychiatry and Clinical Psychology (2778)
  • Public and Global Health (5584)
  • Radiology and Imaging (1090)
  • Rehabilitation Medicine and Physical Therapy (631)
  • Respiratory Medicine (757)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (288)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (131)